Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV-Associated Oropharyngeal Squamous Cell Carcinoma”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03952585
What this trial is testing

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

Who this might be right for
Basaloid Squamous Cell CarcinomaClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+5 more
National Cancer Institute (NCI) 384
Large-scale testing (Phase 3)UnknownNCT01855451
What this trial is testing

Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Trans Tasman Radiation Oncology Group 189
Early research (Phase 1)Study completedNCT04572100
What this trial is testing

Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
University of Chicago 50
Testing effectiveness (Phase 2)WithdrawnNCT02298595
What this trial is testing

Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Carcinoma, SquamousSquamous Cell CarcinomaOropharyngeal Neoplasms+1 more
Julie E. Bauman, MD, MPH
Testing effectiveness (Phase 2)Study completedNCT01084083
What this trial is testing

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

Who this might be right for
Head and Neck CancerPrecancerous Condition
Eastern Cooperative Oncology Group 90
Early research (Phase 1)Looking for participantsNCT06747390
What this trial is testing

Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (OPSCCA)Oropharyngeal CancerHuman Papilloma Virus+1 more
Ryan Carey 30
Testing effectiveness (Phase 2)Study completedNCT03077243
What this trial is testing

P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC

Who this might be right for
Carcinoma, Squamous CellHead and Neck NeoplasmsOropharyngeal Neoplasms
UNC Lineberger Comprehensive Cancer Center 195
Large-scale testing (Phase 3)Study completedNCT01302834
What this trial is testing

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

Who this might be right for
Head and Neck CancerPrecancerous Condition
Radiation Therapy Oncology Group 987
Testing effectiveness (Phase 2)Study completedNCT02048020
What this trial is testing

Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer

Who this might be right for
Human Papilloma Virus InfectionStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the Larynx+13 more
Jonsson Comprehensive Cancer Center 26
Not applicableLooking for participantsNCT03875716
What this trial is testing

Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 111
Testing effectiveness (Phase 2)Active Not RecruitingNCT05714657
What this trial is testing

Shortened Course Adjuvant Radiotherapy Following TORS

Who this might be right for
HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Abramson Cancer Center at Penn Medicine 104
Not applicableEnded earlyNCT05061940
What this trial is testing

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Who this might be right for
Head and Neck CancerMelanomaHPV-Related Malignancy+5 more
Repertoire Immune Medicines 22
Testing effectiveness (Phase 2)Looking for participantsNCT05686226
What this trial is testing

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Who this might be right for
Cervical CancerThroat CancerOropharynx Cancer+18 more
Christian Hinrichs 20
Early research (Phase 1)WithdrawnNCT03575234
What this trial is testing

Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer

Who this might be right for
Human Papillomavirus Positive Oropharyngeal Squamous Cell CarcinomaStage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+2 more
Emory University
Testing effectiveness (Phase 2)Study completedNCT01932697
What this trial is testing

Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer

Who this might be right for
Human Papillomavirus InfectionStage I Oropharyngeal Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell Carcinoma+3 more
Mayo Clinic 81
Testing effectiveness (Phase 2)Ended earlyNCT01525927
What this trial is testing

Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity

Who this might be right for
Oropharyngeal Neoplasms
Northwell Health 2
Testing effectiveness (Phase 2)Looking for participantsNCT06223568
What this trial is testing

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckOropharynxHuman Papillomavirus Viruses+2 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Looking for participantsNCT06319963
What this trial is testing

Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Who this might be right for
HPV-Related Cervical CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Theravectys S.A. 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06759155
What this trial is testing

Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
OPSCCOropharyngeal Squamous Cell Carcinoma (SCC)HPV Associated Cancers
University of Vermont Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT04900623
What this trial is testing

Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

Who this might be right for
HPV-Associated Oropharyngeal Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell CarcinomaHPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Stage+9 more
Jonathan Schoenfeld, MD, MPH 145
Load More Results